Exelixis (EXEL) Tops Q4 EPS by 13c

Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.12, $0.13 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $77.6 million versus the consensus estimate of $66.5 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c